Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, June 2013

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 3 patents

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 36 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Gene mutations and copy number alterations of EGFR, KRAS and MET

Grant US-11085086-B2

United States of America

Dosage and administration of anti-EGFR therapeutics

Grant US-9920131-B2

United States of America

Dosage and administration of anti-EGFR therapeutics

Grant US-9657108-B2

United States of America